Randomized Double-Blind Trial on Safety and Efficacy of Nanordica Advanced Antibacterial Wound Dressing for Diabetic Foot Ulcer

NARecruitingINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

October 17, 2024

Primary Completion Date

October 31, 2025

Study Completion Date

June 30, 2026

Conditions
Diabetic Foot UlcerDiabetic Foot Infection
Interventions
DEVICE

Advanced Antibacterial Wound Dressing

For the first 4 weeks, wound dressing will be changed twice weekly. Subsequently, dressing selection and change frequency will be managed by the investigator as part of the standard of care for another 8 weeks.

DEVICE

Aquacel Ag+ Extra

For the first 4 weeks, wound dressing will be changed twice weekly. Subsequently, dressing selection and change frequency will be managed by the investigator as part of the standard of care for another 8 weeks.

Trial Locations (11)

Unknown

RECRUITING

East Tallinn Central Hospital, Tallinn

RECRUITING

North Estonia Medical Centre Foundation, Tallinn

RECRUITING

Tartu University Hospital, Tartu

RECRUITING

Centro de Salud de Arcos de la Frontera, Arcos de la Frontera

RECRUITING

Hospital Puerta del Mar, Cadiz

RECRUITING

Centro de Salud San Benito, Jerez de la Frontera

RECRUITING

Hospital de León, León

RECRUITING

Clínica Universitaria de Podología de la Universidad Complutense de Madrid, Madrid

RECRUITING

Hospital Ramón y Cajal, Madrid

RECRUITING

Hospital Universitario Fundación Alcorcón, Madrid

RECRUITING

Hospital Universitario de Donostia, San Sebastián

Sponsors
All Listed Sponsors
lead

Nanordica Medical OU

INDUSTRY

NCT06667752 - Randomized Double-Blind Trial on Safety and Efficacy of Nanordica Advanced Antibacterial Wound Dressing for Diabetic Foot Ulcer | Biotech Hunter | Biotech Hunter